English

Eligibility Non-Small-Cell Lung Cancer NCT00550173

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with locally advanced or metastatic nonsquamous non-small cell lung cancer
Description

Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally | Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C4324656
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C1517927
UMLS CUI [2]
C4288755
patients must be non-smokers
Description

Non-smoker

Data type

boolean

Alias
UMLS CUI [1]
C0337672
patients must have at least one measurable lesion
Description

Measurable lesion Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
performance status of 0 to 2 on the eastern cooperative oncology group scale
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
patients must have failed only one prior chemotherapy regimen and must be considered eligible for further chemotherapy following progression of their disease.
Description

Prior Chemotherapy Quantity failed | Disease Progression | Eligibility Chemotherapy Additional

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0231175
UMLS CUI [2]
C0242656
UMLS CUI [3,1]
C1548635
UMLS CUI [3,2]
C0392920
UMLS CUI [3,3]
C1524062
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication
Description

Drugs, Non-Prescription

Data type

boolean

Alias
UMLS CUI [1]
C0013231
patients who have previously received treatment with drugs against the human epidermal growth factor receptors
Description

Pharmaceutical Preparations Against Epidermal Growth Factor Receptor

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521124
UMLS CUI [1,3]
C0034802
patients who have previously received treatment with drugs which have similar targets as pemetrexed
Description

Pharmaceutical Preparations Pemetrexed Similar

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0210657
UMLS CUI [1,3]
C2348205
patients who have any known significant ophthalmologic abnormalities of the surface of the eye
Description

Eye Abnormalities Surface

Data type

boolean

Alias
UMLS CUI [1,1]
C0015393
UMLS CUI [1,2]
C4321570
patients who have a history of severe hypersensitivity reaction to erlotinib or pemetrexed
Description

Severe allergy erlotinib | Severe allergy pemetrexed

Data type

boolean

Alias
UMLS CUI [1,1]
C2945656
UMLS CUI [1,2]
C1135135
UMLS CUI [2,1]
C2945656
UMLS CUI [2,2]
C0210657
Back to the top of the page

Similar models

Eligibility Non-Small-Cell Lung Cancer NCT00550173

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally | Metastatic Non-Squamous Non-Small Cell Lung Carcinoma
Item
patients with locally advanced or metastatic nonsquamous non-small cell lung cancer
boolean
C4324656 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C4288755 (UMLS CUI [2])
Non-smoker
Item
patients must be non-smokers
boolean
C0337672 (UMLS CUI [1])
Measurable lesion Quantity
Item
patients must have at least one measurable lesion
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
performance status of 0 to 2 on the eastern cooperative oncology group scale
boolean
C1520224 (UMLS CUI [1])
Prior Chemotherapy Quantity failed | Disease Progression | Eligibility Chemotherapy Additional
Item
patients must have failed only one prior chemotherapy regimen and must be considered eligible for further chemotherapy following progression of their disease.
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2])
C1548635 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
C1524062 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Drugs, Non-Prescription
Item
patients who have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication
boolean
C0013231 (UMLS CUI [1])
Pharmaceutical Preparations Against Epidermal Growth Factor Receptor
Item
patients who have previously received treatment with drugs against the human epidermal growth factor receptors
boolean
C0013227 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0034802 (UMLS CUI [1,3])
Pharmaceutical Preparations Pemetrexed Similar
Item
patients who have previously received treatment with drugs which have similar targets as pemetrexed
boolean
C0013227 (UMLS CUI [1,1])
C0210657 (UMLS CUI [1,2])
C2348205 (UMLS CUI [1,3])
Eye Abnormalities Surface
Item
patients who have any known significant ophthalmologic abnormalities of the surface of the eye
boolean
C0015393 (UMLS CUI [1,1])
C4321570 (UMLS CUI [1,2])
Severe allergy erlotinib | Severe allergy pemetrexed
Item
patients who have a history of severe hypersensitivity reaction to erlotinib or pemetrexed
boolean
C2945656 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
C2945656 (UMLS CUI [2,1])
C0210657 (UMLS CUI [2,2])
Back to the top of the page